Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 12/20 | 0.70 |
| ▸ | SLC6A4 | P31645 | 12/20 | 0.70 |
| ▸ | NOS2 | P35228 | 11/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 10/20 | 0.70 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.42 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.42 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | TDO2 | P48775 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL6504303 | 0.92 | NOS2 (0.74) | SLC6A2SLC6A4NOS2CYP2D6SLC6A3 | |
| Fumaric Acid SCHEMBL6504307 | 0.92 | NOS2 (0.74) | SLC6A2SLC6A4NOS2CYP2D6SLC6A3 | |
| SCHEMBL6505773 | 0.82 | NOS2 (1.00) | SLC6A2SLC6A4NOS2CYP2D6KCNH2 | |
| Fumaric Acid SCHEMBL6494416 | 0.75 | NOS2 (1.00) | SLC6A2SLC6A4NOS2CYP2D6KCNH2 | |
| Fumaric Acid SCHEMBL6494424 | 0.75 | NOS2 (1.00) | SLC6A2SLC6A4NOS2CYP2D6KCNH2 | |
| SCHEMBL6503738 | 0.75 | SLC6A2 (0.74) | SLC6A2SLC6A4NOS2CYP2D6SLC6A3 | |
| SCHEMBL5653417 | 0.72 | NOS2 (0.81) | SLC6A2SLC6A4NOS2CYP2D6KCNH2 | |
| Hydrochloric Acid SCHEMBL5652171 | 0.71 | NOS2 (0.79) | SLC6A2SLC6A4NOS2CYP2D6KCNH2 | |
| Oxalic Acid SCHEMBL6491750 | 0.71 | NOS2 (0.72) | SLC6A2SLC6A4NOS2CYP2D6SLC6A3 | |
| SCHEMBL8113801 | 0.70 | MAOA (0.51) | SLC6A2SLC6A4NOS2CYP2D6SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6953797-B2 | Use of phenylheteroalkylamine derivatives | ASTRAZENECA AB (SE) | 2005-10-11 | — | — | US | claimed |
| EP-1263718-B1 | NOVEL USE OF PHENYLHETEROALKYLAMINE DERIVATIVES | ASTRAZENECA AB (SE) | 2004-04-28 | — | — | EP | claimed |
| US-20030073685-A1 | Novel use of phenylheteroalkylamine derivatives | ASTRAZENECA AB (SE) | 2003-04-17 | — | — | US | claimed |
| EP-1263718-A1 | NOVEL USE OF PHENYLHETEROALKYLAMINE DERIVATIVES | AstraZeneca AB (SE) | 2002-12-11 | — | — | EP | claimed |
| WO-2001062721-A1 | NOVEL USE OF PHENYLHETEROALKYLAMINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-08-30 | — | — | WO | claimed |
| US-6953797-B2 | Use of phenylheteroalkylamine derivatives | ASTRAZENECA AB (SE) | 2005-10-11 | — | — | US | disclosed |
| EP-1263718-B1 | NOVEL USE OF PHENYLHETEROALKYLAMINE DERIVATIVES | ASTRAZENECA AB (SE) | 2004-04-28 | — | — | EP | disclosed |
| US-20030073685-A1 | Novel use of phenylheteroalkylamine derivatives | ASTRAZENECA AB (SE) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030073685-A1 | Novel use of phenylheteroalkylamine derivatives | CYP1A1, CYP1A2, CYP2E1 | SLC6A2 1769/4885SLC6A4 1977/4885NOS2 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.